Viemed Healthcare (NASDAQ:VMD – Get Free Report) posted its quarterly earnings results on Monday. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.05), FiscalAI reports. Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. The business had revenue of $78.10 million during the quarter, compared to the consensus estimate of $78.00 million.
Viemed Healthcare Stock Up 0.2%
VMD traded up $0.02 during trading on Monday, hitting $11.69. The stock had a trading volume of 400,989 shares, compared to its average volume of 267,900. The company has a market capitalization of $448.16 million, a PE ratio of 31.59 and a beta of 1.10. Viemed Healthcare has a twelve month low of $5.96 and a twelve month high of $12.61. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.10 and a current ratio of 1.22. The stock has a 50 day simple moving average of $11.12 and a two-hundred day simple moving average of $9.66.
Insider Activity
In related news, Director Timothy Smokoff sold 20,000 shares of the company’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total transaction of $230,000.00. Following the transaction, the director directly owned 75,518 shares of the company’s stock, valued at $868,457. This represents a 20.94% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider William Frazier sold 10,000 shares of the firm’s stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $11.72, for a total value of $117,200.00. Following the completion of the sale, the insider directly owned 73,214 shares of the company’s stock, valued at approximately $858,068.08. This represents a 12.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 20.60% of the company’s stock.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “hold (c+)” rating on shares of Viemed Healthcare in a report on Friday, July 17th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold”.
Get Our Latest Analysis on VMD
About Viemed Healthcare
Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.
Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.
See Also
- Five stocks we like better than Viemed Healthcare
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
